Related references
Note: Only part of the references are listed.Recessive mutations in the cancer gene Ataxia Telangiectasia Mutated (ATM), at a locus previously associated with metformin response, cause dysglycaemia and insulin resistance
P. J. Connelly et al.
DIABETIC MEDICINE (2016)
Liver Disease in Pediatric Patients With Ataxia Telangiectasia: A Novel Report
Batia Weiss et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2016)
Serum Interleukin-6 Levels and Pulmonary Function in Ataxia-Telangiectasia
Sharon A. McGrath-Morrow et al.
JOURNAL OF PEDIATRICS (2016)
Endocrine abnormalities in ataxia telangiectasia: findings from a national cohort
Andreea Nissenkorn et al.
PEDIATRIC RESEARCH (2016)
Risk of Atherosclerosis in Patients with Ataxia Telangiectasia
Itana Gomes Alves Andrade et al.
ANNALS OF NUTRITION AND METABOLISM (2015)
Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis
C. J. Harbort et al.
BLOOD (2015)
Association between a gene variant near ataxia telangiectasia mutated and coronary artery disease in men
Stephan Schiekofer et al.
DIABETES & VASCULAR DISEASE RESEARCH (2014)
Growth retardation and growth hormone deficiency in patients with Ataxia telangiectasia
Sandra Voss et al.
GROWTH FACTORS (2014)
Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions
Mark Ambrose et al.
BLOOD (2013)
The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease
Erin K. Daugherity et al.
CELL CYCLE (2012)
ATM protects against oxidative stress induced by oxidized low-density lipoprotein
Michaela Semlitsch et al.
DNA REPAIR (2011)
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
Kaixin Zhou et al.
NATURE GENETICS (2011)
DNA Damage Links Mitochondrial Dysfunction to Atherosclerosis and the Metabolic Syndrome
John R. Mercer et al.
CIRCULATION RESEARCH (2010)
Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease
Rhiannon N. Hardwick et al.
DRUG METABOLISM AND DISPOSITION (2010)
Elevated Serum IL-8 Levels in Ataxia Telangiectasia
Sharon A. McGrath-Morrow et al.
JOURNAL OF PEDIATRICS (2010)
Association of Carotid Intima-media Thickness and Cardiovascular Risk Factors in Women Pre- and Post-bariatric Surgery
P. L. F. A. Sarmento et al.
OBESITY SURGERY (2009)
ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells
Marie-Jo Halaby et al.
CELLULAR SIGNALLING (2008)
Lipid screening and cardiovascular health in childhood
Stephen R. Daniels et al.
PEDIATRICS (2008)
Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals
Alain Simon et al.
EUROPEAN HEART JOURNAL (2007)
ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome
Jochen G. Schneider et al.
CELL METABOLISM (2006)
Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: The Bogalusa Heart Study
Sathanur R. Srinivasan et al.
PEDIATRICS (2006)
Proposed mechanisms for the induction of insulin resistance by oxidative stress
A Bloch-Damti et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Heterozygous mutation of ataxia-telangiectasia mutated gene aggravates hypercholesterolemia in apoE-deficient mice
DF Wu et al.
JOURNAL OF LIPID RESEARCH (2005)
The molecular basis for oxidative stress-induced insulin resistance
JL Evans et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
E Bugianesi et al.
DIABETOLOGIA (2005)
Elevated oxidative stress in patients with ataxia telangiectasia
J Reichenbach et al.
ANTIOXIDANTS & REDOX SIGNALING (2002)
Participation of ATM in insulin signalling through phosphorylation of eIf-4E-binding protein 1
DQ Yang et al.
NATURE CELL BIOLOGY (2000)